STAAR SURGICAL CO (STAA)

Nasdaq · Ophthalmic Goods

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

Corporate structure

7 entities across 6 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-03-03 — see the exhibit.

Which other public companies file entities in the same places:

China2 United Kingdom1 Switzerland1 Japan1 Singapore1 India1

Subsidiaries of STAAR SURGICAL CO as disclosed in its SEC filing
Entity	Jurisdiction	Note
STAAR Surgical UK LTD	United Kingdom
STAAR Surgical AG	Switzerland
STAAR Japan Inc.	Japan
STAAR Surgical PTE. LTD	Singapore
STAAR Optical Equipment Technology (Shanghai) Co., LTD	China
STAAR Surgical CHINA CO., LTD	China
STAAR Surgical India Private Limited	India

Financial health

Two standard screens, computed from the XBRL in FY2026 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

1 / 8

FAILReturn on assets positiveROA -17.8%
FAILOperating cash flow positiveOCF -34M
FAILReturn on assets improving-4.0% → -17.8%
PASSCash flow exceeds earningsOCF -34M vs NI -80M
FAILLong-term debt ratio fallingno debt reported
FAILCurrent ratio improving5.23 → 4.55
FAILNo share dilution49M → 50M shares
FAILGross margin improving76.3% → 76.2%
FAILAsset turnover improving0.62× → 0.53×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2021	$163.5M	$5.9M	$12.5M	72.4%	47,953,000
FY2021	$230.5M	$24.5M	$30.3M	77.5%	49,456,000
FY2022	$284.4M	$38.8M	$17.6M	78.5%	49,380,000
FY2023	$322.4M	$21.3M	−$3.6M	78.4%	49,427,000
FY2024	$313.9M	−$20.2M	−$7.7M	76.3%	49,125,000
FY2026	$239.4M	−$80.4M	−$40.0M	76.2%	49,568,000

Ownership flow

13 institutions tracked — 8 added, 3 reduced, 2 opened a new position.

Institutional holders of STAAR SURGICAL CO and their share-count change
Manager	Kind	Shares	Change	Value
Point72 Asset Management, L.P.	Hedge fund	2,437,446	+1,614,294	$69.9M
CITADEL ADVISORS LLC	Hedge fund	432,784	−839,444	$12.4M
RENAISSANCE TECHNOLOGIES LLC	Hedge fund	340,400	+205,200	$9.8M
MORGAN STANLEY	Active fund	1,316,119	−183,237	$37.8M
BANK OF AMERICA CORP /DE/	Active fund	183,775	+119,030	$5.3M
JPMORGAN CHASE & CO	Active fund	112,316	+75,022	$3.3M
BlackRock, Inc.	Index	6,731,154	+65,036	$193.1M
STATE STREET CORP	Index	1,769,354	−63,642	$50.8M
GEODE CAPITAL MANAGEMENT, LLC	Index	1,076,006	+59,502	$30.9M
PRICE T ROWE ASSOCIATES INC /MD/	Active fund	60,166	+8,624	$1.7M
FMR LLC	Active fund	17,624	+455	$505,619

NORGES BANK, AQR CAPITAL MANAGEMENT LLC hold a position with no prior filing to compare against, so their change is unknown rather than zero — and they are left out of the totals above.

From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.

Identity

CIK: 0000718937
SIC: 3851 · Ophthalmic Goods
Incorporated: DE
Headquarters: MONROVIA, CA

Ownership

Institutional: 111.5%
Institutions: 281
Insiders: 0.9%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Other ophthalmic goods companies

STAAR SURGICAL CO files under SIC 3851 — all 3 ophthalmic goods companies compared on assets and F-score.

Bausch & Lomb CorpBLCO COOPER COMPANIES, INC.COO

Questions about STAAR SURGICAL CO

How many subsidiaries does STAAR SURGICAL CO file with the SEC?: 7, listed in its most recent exhibit 21. They are incorporated across 6 jurisdictions, led by United Kingdom, Switzerland, Japan. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is STAAR SURGICAL CO financially healthy?: STAAR SURGICAL CO scores 1 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of STAAR SURGICAL CO?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are BlackRock, Inc. (adding), Point72 Asset Management, L.P. (adding), STATE STREET CORP (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.

Corporate structure

7 entities across 6 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-03-03 — see the exhibit.

Entity

Jurisdiction

Note

STAAR Surgical UK LTD

United Kingdom

STAAR Surgical AG

Switzerland

STAAR Japan Inc.

Japan

STAAR Surgical PTE. LTD

Singapore

STAAR Optical Equipment Technology (Shanghai) Co., LTD

China

STAAR Surgical CHINA CO., LTD

China

STAAR Surgical India Private Limited

India

Financial health

Two standard screens, computed from the XBRL in FY2026 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

1 / 8

FAILReturn on assets positiveROA -17.8%
FAILOperating cash flow positiveOCF -34M
FAILReturn on assets improving-4.0% → -17.8%
PASSCash flow exceeds earningsOCF -34M vs NI -80M
FAILLong-term debt ratio fallingno debt reported
FAILCurrent ratio improving5.23 → 4.55
FAILNo share dilution49M → 50M shares
FAILGross margin improving76.3% → 76.2%
FAILAsset turnover improving0.62× → 0.53×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2021	$163.5M	$5.9M	$12.5M	72.4%	47,953,000
FY2021	$230.5M	$24.5M	$30.3M	77.5%	49,456,000
FY2022	$284.4M	$38.8M	$17.6M	78.5%	49,380,000
FY2023	$322.4M	$21.3M	−$3.6M	78.4%	49,427,000
FY2024	$313.9M	−$20.2M	−$7.7M	76.3%	49,125,000
FY2026	$239.4M	−$80.4M	−$40.0M	76.2%	49,568,000

Ownership flow

13 institutions tracked — 8 added, 3 reduced, 2 opened a new position.

Institutional holders of STAAR SURGICAL CO and their share-count change
Manager	Kind	Shares	Change	Value
Point72 Asset Management, L.P.	Hedge fund	2,437,446	+1,614,294	$69.9M
CITADEL ADVISORS LLC	Hedge fund	432,784	−839,444	$12.4M
RENAISSANCE TECHNOLOGIES LLC	Hedge fund	340,400	+205,200	$9.8M
MORGAN STANLEY	Active fund	1,316,119	−183,237	$37.8M
BANK OF AMERICA CORP /DE/	Active fund	183,775	+119,030	$5.3M
JPMORGAN CHASE & CO	Active fund	112,316	+75,022	$3.3M
BlackRock, Inc.	Index	6,731,154	+65,036	$193.1M
STATE STREET CORP	Index	1,769,354	−63,642	$50.8M
GEODE CAPITAL MANAGEMENT, LLC	Index	1,076,006	+59,502	$30.9M
PRICE T ROWE ASSOCIATES INC /MD/	Active fund	60,166	+8,624	$1.7M
FMR LLC	Active fund	17,624	+455	$505,619

NORGES BANK, AQR CAPITAL MANAGEMENT LLC hold a position with no prior filing to compare against, so their change is unknown rather than zero — and they are left out of the totals above.

Questions about STAAR SURGICAL CO

How many subsidiaries does STAAR SURGICAL CO file with the SEC?

7, listed in its most recent exhibit 21. They are incorporated across 6 jurisdictions, led by United Kingdom, Switzerland, Japan. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is STAAR SURGICAL CO financially healthy?

STAAR SURGICAL CO scores 1 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of STAAR SURGICAL CO?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are BlackRock, Inc. (adding), Point72 Asset Management, L.P. (adding), STATE STREET CORP (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.